PMID- 38153351 OWN - NLM STAT- MEDLINE DCOM- 20231229 LR - 20240106 IS - 2573-7732 (Electronic) IS - 2573-7732 (Linking) VI - 7 IP - 12 DP - 2023 Dec 1 TI - Egr2 Deletion in Autoimmune-Prone C57BL6/lpr Mice Suppresses the Expression of Methylation-Sensitive Dlk1-Dio3 Cluster MicroRNAs. PG - 898-907 LID - 10.4049/immunohorizons.2300111 [doi] AB - We previously demonstrated that the upregulation of microRNAs (miRNAs) at the genomic imprinted Dlk1-Dio3 locus in murine lupus is correlated with global DNA hypomethylation. We now report that the Dlk1-Dio3 genomic region in CD4+ T cells of MRL/lpr mice is hypomethylated, linking it to increased Dlk1-Dio3 miRNA expression. We evaluated the gene expression of methylating enzymes, DNA methyltransferases (DNMTs), and demethylating ten-eleven translocation proteins (TETs) to elucidate the molecular basis of DNA hypomethylation in lupus CD4+ T cells. There was a significantly elevated expression of Dnmt1 and Dnmt3b, as well as Tet1 and Tet2, in CD4+ T cells of three different lupus-prone mouse strains compared to controls. These findings suggest that the hypomethylation of murine lupus CD4+ T cells is likely attributed to a TET-mediated active demethylation pathway. Moreover, we found that deletion of early growth response 2 (Egr2), a transcription factor gene in B6/lpr mice markedly reduced maternally expressed miRNA genes but not paternally expressed protein-coding genes at the Dlk1-Dio3 locus in CD4+ T cells. EGR2 has been shown to induce DNA demethylation by recruiting TETs. Surprisingly, we found that deleting Egr2 in B6/lpr mice induced more hypomethylated differentially methylated regions at either the whole-genome level or the Dlk1-Dio3 locus in CD4+ T cells. Although the role of methylation in EGR2-mediated regulation of Dlk1-Dio3 miRNAs is not readily apparent, these are the first data to show that in lupus, Egr2 regulates Dlk1-Dio3 miRNAs, which target major signaling pathways in autoimmunity. These data provide a new perspective on the role of upregulated EGR2 in lupus pathogenesis. CI - Copyright (c) 2023 The Authors. FAU - Wang, Zhuang AU - Wang Z AUID- ORCID: 0000-0001-7822-829X AD - Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA. FAU - Heid, Bettina AU - Heid B AD - Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA. FAU - He, Jianlin AU - He J AD - Epigenomics and Computational Biology Lab, Fralin Life Sciences Institute at Virginia Tech, Blacksburg, VA. FAU - Xie, Hehuang AU - Xie H AD - Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA. AD - Epigenomics and Computational Biology Lab, Fralin Life Sciences Institute at Virginia Tech, Blacksburg, VA. FAU - Reilly, Christopher M AU - Reilly CM AUID- ORCID: 0000-0003-4787-7750 AD - Department of Cell Biology and Physiology, Edward Via College of Osteopathic Medicine, Blacksburg, VA. FAU - Dai, Rujuan AU - Dai R AUID- ORCID: 0000-0002-1074-8974 AD - Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA. FAU - Ahmed, S Ansar AU - Ahmed SA AUID- ORCID: 0000-0001-5913-7501 AD - Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA. LA - eng GR - 180472/VMCVM Internal Research Competition (IRC) program/ PT - Journal Article PL - United States TA - Immunohorizons JT - ImmunoHorizons JID - 101708159 RN - 0 (MicroRNAs) RN - 9007-49-2 (DNA) RN - 0 (Dlk1 protein, mouse) RN - 0 (Calcium-Binding Proteins) RN - 0 (Egr2 protein, mouse) RN - 0 (Early Growth Response Protein 2) SB - IM MH - Animals MH - Mice MH - Mice, Inbred MRL lpr MH - *DNA Methylation MH - Autoimmunity MH - Mice, Inbred C57BL MH - *MicroRNAs/genetics MH - DNA MH - Calcium-Binding Proteins/genetics MH - Early Growth Response Protein 2 PMC - PMC10759154 COIS- The authors have no financial conflicts of interest. EDAT- 2023/12/28 12:42 MHDA- 2023/12/29 06:42 PMCR- 2023/12/28 CRDT- 2023/12/28 10:03 PHST- 2023/12/05 00:00 [received] PHST- 2023/12/06 00:00 [accepted] PHST- 2023/12/29 06:42 [medline] PHST- 2023/12/28 12:42 [pubmed] PHST- 2023/12/28 10:03 [entrez] PHST- 2023/12/28 00:00 [pmc-release] AID - 266574 [pii] AID - immunohorizons_2300111 [pii] AID - 10.4049/immunohorizons.2300111 [doi] PST - ppublish SO - Immunohorizons. 2023 Dec 1;7(12):898-907. doi: 10.4049/immunohorizons.2300111.